Biography/Memoir

…Sacklers’ immunity threatened as Department of Justice moves to block opioid deal

The Department of Justice is fighting to strip the billionaire Sackler family of the sweeping legal immunity granted as part of a controversial $4.5 billion opioid settlement. …in filings, DOJ trustee Harrington argued that the releases are unconstitutional because they deprive people of the ability to make legal claims – a form of property – against the…

READ MORE
Biography/Memoir

The Sackler deal… will it hold? Oregon Attorney General weighing an appeal…

Oregon Attorney General Ellen Rosenblum said she was weighing an appeal… the questioning of Sackler in the 337-page deposition centered on Purdue’s marketing of OxyContin. Following the release of the revealing deposition’s contents – which Purdue fought for three years to keep secret… the settlement denies the thousands of plaintiffs – whose lawsuits total a staggering $40 trillion – their…

READ MORE
Biography/Memoir

Federal bankruptcy judge grants Sackler family sweeping immunity in $4.3 billion opioid settlement

More than two-thirds of Congress cashed a pharma campaign check in 2020… the ruling, which is exactly what the Sacklers demanded, grants releases from liability for harm caused by the company’s aggressive and sometimes illegal marketing of the discontinued opioid OxyContin and other opioids. In addition to the Sacklers themselves, hundreds of individuals and organizations…

READ MORE
Biography/Memoir

In emails, Sacklers fret over wealth, opioid business

According to Forbes, the Sackler family made $12 billion to $13 billion in profit from OxyContin manufacturer Purdue Pharma—much more than what was previously known, according to the Wall Street Journal, citing court records. On Wednesday [10/21/2020], Sackler family members associated with Purdue agreed to pay a $225 million penalty to resolve a Justice Department civil probe…

READ MORE
Biography/Memoir

OxyContin maker to plead guilty to federal criminal charges, [indirectly “pay”] $8 billion, and will close the company

Twenty-five state attorneys general wrote to US Attorney General William Barr last week [mid-October] arguing against the plan to create a government-controlled company out of the assets of Purdue Pharma, arguing that the government should not be in the business of selling OxyContin. The company doesn’t have $8 billion in cash available to pay the…

READ MORE
Biography/Memoir

Purdue’s Sackler family wants global opioids settlement: Sackler lawyer Mary Jo White

In… public comments on behalf of the Sacklers, White told me why the family believed the litigation against them and their company is legally dubious, factually misleading and politically motivated. The claims are gargantuan: An expert plaintiffs’ witness in the nationwide MDL in Cleveland recently estimated that it will cost nearly half a trillion dollars…

READ MORE
Biography/Memoir

Lawsuits puts pressure on family that owns opioid company

The legal pressure on the prominent family behind the company that makes OxyContin, the prescription painkiller that helped fuel the nation’s opioid epidemic, is likely to get more intense … Having Sackler family members named as defendants in Massachusetts “indicates that the government attorneys believe they have the ‘smoking guns’ necessary to broaden the potential liability…

READ MORE
Biography/Memoir

New York Attorney General slams Sacklers’ tepid financial info disclosures

New York’s attorney general… told a U.S.bankruptcy [on April 29th, 2020] court that the Sackler family, owners of Purdue Pharma LP, have slow-rolled and resisted discovery requests into their finanancial information. AG Letitia James said that the Sackler’s have produced few primary documents in the six months to make voluntary disclosures about their finances. The…

READ MORE
Biography/Memoir

Meet the Sacklers

What some call philanthropy, others, such as Stanford University ethics professor Rob Reich, call “reputation laundering”. But what’s less well known, though increasingly being exposed, is that much of their wealth comes from one product – OxyContin, the blockbuster prescription painkiller first launched in 1996. “Greed is the main thing. The market for OxyContin should have been much,…

READ MORE